The development of new vectors to deliver DNA into cells for therapy of cancers or genetic diseases has been a major area of research for many years. However, the clinical application of this technology requires the development of efficient, reliable and sterile vectors enabling the transfer of genes in vivo. Non viral, polymer or lipid-based vectors offer a new impetus to gene therapy because they are less toxic than viral vectors (no endogenous recombination, fewer immunological reactions, easy production and delivery of large-sized plasmid).
Introduction
In recent years, gene delivery systems have attracted much attention (1, 2) . Two types of carrier can be used to deliver DNA or RNA to the target cells or tissues: viral or non-viral vectors. Viral vectors have been largely used for in-vivo gene transfer because they provide efficient intracellular delivery and high, sustained gene expression (3). However, these vectors are limited by complicated formulation, restricted gene size, and immunogenicity (4). Therefore, non-viral vector delivery systems are being developed as safer alternatives that can be administered repeatedly with low immune response, are targeted to cells or tissues targeting, not limited by plasmid size and easy to produce in large quantities (5).
Among the non-viral carriers that have been proposed are cationic liposomes (6-9), nanoemulsions (10), micelles (11), polymeric microparticles (12) and nanoparticles Technology in Cancer Research & Treatment, Volume 8, Number 6, December 2009 (13). Polymer-based systems have been preferred recently (1, 2, 14) since they generally possess favorable physicochemical characteristics such as loading capacity, stability and versatility (15) (16) (17) (18) . Several polymers, such as chitosan (19) , polyethyleneimine (PEI) (20) (21) (22) (23) , polymethacrylates (24), poly (DL-lactide-co-glycolide acid) (PLGA) (25) and poly (DL-lactic acid) (PLA) (26) have been investigated as a means of achieving safe and sustained gene transfection.
Many physico-chemical parameters can affect the transfection efficiency of nanoparticles, including polymer type or molecular weight, nanoparticle size and charge. For example, it has been shown that particle size has a considerable influence on their uptake by tissues and cells. Furthermore, some cell lines can only take up submicron size particles efficiently but not larger sized microparticles (27, 28) . Two different strategies for incorporating DNA into particles have been used: either encapsulation within the polymer matrix (29) or adsorption onto the surface of cationic particles (30) (31) (32) .
In-vivo administration of DNA-encapsulating particles have shown promising results in the development of non-viral vectors for gene therapy of cancer, and demonstrated the potential of both polymeric micro-and nanoparticles to improve cancer treatment. For example, Kasturi et al., (33) demonstrated that the use of PEI-conjugated PLGA microspheres, intended to deliver the MCP3-sFv20 pDNA vaccine after intradermal or intramuscular injection, were able to immunize mice to a significantly higher degree compared with naked vaccine; in addition, they were comparable to a gene gun when injected intramuscularly. However, some fundamental limitations of microparticle preparation remain, such as low encapsulation efficiency, inability to escape phagolysosomes and low bioavailability. In addition, chemical, thermal and mechanical stresses during the production of particles may lead to extensive DNA degradation (34).
More recently, with a view to limiting DNA degradation during the formulation process, Singh et al., (2000) and Esposito et al., (1999) have adsorbed the plasmid onto the surface of cationic particles (30, 31) . Plasmid DNA is a polyanionic molecule which can be loaded on a polycationic surface by ionic interactions. Furthermore, the cationic surfactants and/ or the cationic polymers constituting the cationic particles improve not only plasmid loading but also particle adsorption onto the cell surface (35).
In this study, we report the preparation of DNA-loaded nanoparticles from methacrylate ammonium polycationic polymers (Eudragit ® RS and RL). The aim was to compare two preparation techniques: nanoprecipitation and double emulsion, in terms of their transfection efficiency. Both preparation methods are known to yield particles with diameters in the nano-meter rather than in the micrometer range. The DNA-loaded nanoparticles were characterized and evaluated for their ability to transfect different cells types in vitro, using the marketed Lipofectamine 2000 ® kit as a point of comparison.
Materials and Methods

Materials
Plasmid pEGFP-C3 coding for Green Fluorescent Protein (GFP) was obtained from Clontech (Montigny le Bretonneux, France). Eudragit ® RS PO and RL PO (MW 150,000 Da) polymers, used for the nanoparticle preparation, are acrylic polycationic copolymers of acrylic and methacrylic acid esters with a proportion of quaternary ammonium groups (0.5-0.8% and 0.8-1.2% respectively). These were generously provided by Evonik polymers (Darmstadt, Germany). The surfactants Pluronic F 68 and poly(vinyl alcohol) (99% hydrolyzed) (PVA) were obtained from Sigma Aldrich (Saint-Quentin Fallavier, France). Cell culture media Dulbecco's Modified Eagle Medium (DMEM) and Roswell Park Memorial Institute 1640 (RPMI 1640) medium were obtained from Life Technology (Ergy, France). Lipofectamine 2000 ® transfection reagent, a cationic lipid, was purchased from Invitrogen (Cergy-Pontoise, France).
Preparation of Cationic Nanoparticles
nanoprecipitation Method: The Eudragit ® nanoparticles were prepared as previously described (36, 37) . Briefly, 300 mg of the polymer were dissolved in 15 ml of acetone. This solution was poured in the body of a glass syringe (2 mm diameter tip), and allowed to flow slowly into 50 ml of aqueous Pluronic F68 ® phase (0.5% w/v) under magnetic stirring (550 rpm). The organic solvent was removed by rotary evaporation under vacuum at 40°C (Heidolph, Schwabach, Germany) until 10 ml of nanoparticle suspension were obtained.
Double Emulsion Method:
A double emulsion was prepared as previously described (38). Briefly, 250 mg of polymer were dissolved in 10 ml of dichloromethane (DCM). Water (1 ml), was emulsified into this organic phase by sonication (80W for 30s) using an ultrasonic homogenizer (Vibracell 75022, Bioblock, Illkirch, France) . This primary water-inoil (w/o) emulsion was then dispersed by sonication (80W for 1min) into 40 ml of an aqueous solution of PVA (0.1% w/v) producing a secondary water-in-oil-in-water (w/o/w) emulsion. After evaporation of the organic phase at 40°C, the resultant nanoparticles were harvested by centrifugation (42,000 g, 20 min) and re-suspended in 10 ml Milli-Q water to obtain the final nanosuspension.
Malvern Zetasizer 3000E (Malvern Instruments, Worcestershire, UK). Each sample was measured in triplicate and the results are expressed as the mean of the three measurements.
Quantification of DNA loading
Determination of DnA Loading Efficiency: The loading efficiency of DNA adsorbed onto nanoparticles prepared by the double emulsion method was obtained from the determination of free DNA in the supernatant after centrifugation (42,000 g, 20 min), by measuring the absorbance at 260 nm. Supernatant recovered from unloaded nanoparticles (without DNA) was used as a blank. DNA loading efficiency was expressed as adsorbed DNA (difference between the total amount of DNA added for the particle preparation and the amount of non-absorbed DNA remaining in the supernatant after centrifugation) as a percentage of the total amount of added DNA.
Gel Electrophoresis: DNA-loaded nanoparticles prepared by the nanoprecipitation method were submitted to electrophoresis on a 0.8% agarose gel for 30 min at 90V/cm (Bio-Rad, Marnes-la-coquette, France). Different concentrations of plasmid (25, 50, 100, 300, 500 ng) were used for calibration. Nanoparticles without DNA were used to determine the background level. Images were acquired using a Geldoc 2000 gel documentation system (Bio-Rad, Marnes-la-Coquette, France) equipped with a UV transluminator. Molecular Analyst, version 1.1 software (Bio-Rad, Marnes-la-Coquette, France) was used for band integration and background correction.
Cell lines
FaDu pharynx carcinoma cells were kindly provided by Pr A. Hanauske (Munich University, Germany). MDA-MB 231 and MCF-7 human breast adenocarcinoma cells were provided by Pr P. Becuwe (Nancy University, France) (39). FaDu cells were grown in DMEM medium. MDA-MB 231 and MCF-7 cells were grown in RPMI 1640 medium. The media were supplemented with 10% heat inactivated fetal bovine serum (FBS), 1% penicillin-streptomycin antibiotic mixture, 1% L-Glutamine 200 mM and 1% MEM non essential amino acid.
Cytotoxicity evaluation by MTT Assay
The cytotoxicity of the nanoparticles was determined by the (3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) MTT assay. This assay is based on the ability of living cells to reduce the water-soluble yellow dye, MTT, to purple water-insoluble formazan product by mitochondrial enzyme
Plasmid DNA Preparation
Plasmid pEGFP-C3 encoding the green fluorescent protein (GFP) was propagated in e.Coli and isolated using Marligen maxiprep high purity plasmid purification columns (Clinisciences, Montrouge, France). Plasmid DNA structure and purity were followed by agarose gel (0.8%) electrophoresis (Bio-Rad, Marnes-la-Coquette, France) in the presence of ethidium bromide to detect DNA bands. The DNA concentration in the preparation was determined by UV spectrophotometry (Uvikon 922, Kontron, Eching, Germany) at 260 nm.
Plasmid DNA loading onto Nanoparticles
Loading of the pEGFP-C3 plasmid was performed by adsorption on the surface of the freshly prepared nanoparticles. Before adsorption, unloaded "nanoprecipitation" nanoparticles were sterilized by filtration (0.22 µm). Due to their larger size, nanoparticles prepared by double emulsion were only filtered on a 0.8 µm filter (Chromafil ® , Macherey Nagel, Hoerd, France): sterility could still be assumed since no contamination was ever observed. A constant amount of plasmid (4 µg) was added into the nanoparticle suspension at different polymer concentrations (30, 60, 125, 250 and 500 µg/ml) at room temperature for 30 min.
The yield of the manufacturing, established on 3 different formulations, was calculated by weighing the mass of manufactured nanoparticles (obtained after freeze-drying). The average yields of manufacturing were 83% and 86% for Eudragit ® RS and Eudragit ® RL, respectively. After each preparation, the exact nanosuspension volume (always around 7-8 ml) was determined at the end of the evaporation process. Therefore, the concentration of nanoparticles (mg/ml) in the suspension was obtained by dividing the mass of polymer (determined initially on 3 experiments as explained before) by the volume.
In order to prepare the various nanoparticles concentrations, the exact volume of nanoparticles to be added was calculated and completed to 50 µl with a glucose 5% aqueous solution. The volumes of nanosuspension were determined by taking the exact concentration in a final volume of 50 µl. Then 50 µl of a 5% glucose solution containing 4 µg of DNA was added to the previous 50 µl of nanoparticles suspension. Incubation was maintained for 30 minutes before contact with cells. Nanoparticles were prepared extemporaneously: maximum time between nanoparticles preparation and cell transfection or cytotoxicity studies was 1 hour.
Particle Size and zeta Potential
The nanoparticles with or without DNA were analyzed for their size distribution and their surface potential using a nanoparticles (40). As shown in Table I , the mean diameter of the nanoparticles obtained in this work also depended on the preparation method. Typically, unloaded cationic nanoparticles obtained by nanoprecipitation had a diameter between 39 to 50 nm, while those formed by double emulsion were 350 to 400 nm in diameter. The size of the nanoparticles was not modified by DNA loading, but, as would be expected, the overall charge of the nanoparticles was strongly dependent on adsorbed DNA.
In several studies it has been shown that smaller nanoparticles give higher transfection efficiency than larger nanoparticles or microparticles (28). The choice of the manufacturing method is therefore critical. By using two different techniques, we were able to produce particles with the same composition but with large differences in mean diameter, so that the influence of size, if any, on the transfection process could be easily observed. Only the "nanoprecipitation" nanoparticles actually correspond to the definition of nanoparticles (i.e., size less than 100 nm). "Double emulsion" nanoparticles correspond more to intermediate nano/microparticles. Nevertheless, for the sake of clarity, the word "nanoparticles" will be used for particles obtained by either the nanoprecipitation or the double emulsion process.
The physico-chemical parameters including the type of polymers may influence the transfection. Eudragit ® RS 100 and RL 100 are copolymers based on cationic methacrylic acid esters, easily synthesized, not expensive and widely accepted as pharmaceutical additives. Eudragit ® polymers could offer a number of advantages over other polymers (chitosan, PLGA, polyethylenimine) because they maintain unaltered physico-chemical properties for longer time periods, allowing long-time storage and are suitable for industrial production. The disadvantage of these polymers is their non biodegradability, although they are biocompatible. Nevertheless, Eudragit ® RS has already been used to prepare relatively large nanoparticles (range 0.66 to 1 µm) together with different cationic surfactants for pGL3 transfection (41). However, the size of these nanoparticles was probably too large for uptake by the J774 cell line, which is one potential reason for the low transfection efficiency observed. In addition, the didecyldimethylammonium bromide (DDAB) used to prepare nanoparticles is potentially toxic. To avoid these two limitations, we prepared DDAB-free Eudragit RS and RL nanoparticles with a much smaller diameter.
The surface charge of the DNA system is another critical factor that can influence the transfection efficiency (42). First, it was important to evaluate the stability of DNA binding. This has been done by measuring the zeta potential (as a surrogate of stability) of the Eudragit ® RL-DNA and Eudragit ® RS-DNA nanoparticles for 25 µg of polymer (i.e., nanoparticles) and 4 µg of DNA. Based on the experimental values (not succinate dehydrogenase. Cells were seeded in 24-well plates at 5.10 4 and 1.10 5 cells/well for FaDu and both MDA-MB 231 and MCF-7, respectively. Twenty four hours later, cells were washed twice by PBS. One hundred microliters of nanoparticles without DNA or DNA-loaded nanoparticles were added to 500 µl of serum-free medium at different concentrations of nanoparticles: 30, 60, 125, 250, 500 µg/ml. After a 4h incubation, 500 µl of 20% FBS complete medium were added for each well. After 24h incubation, 250 µl of MTT solution (2.5 mg/ml) were added to cells followed by further incubation for 4h. The formazan crystals formed were dissolved using a 25% aqueous solution of SDS (250 µl/per well). Then, 300 µl per well were transferred in 96-well plates and absorbance was read at 570 nm on a microplate reader. Cell viability was determined as a percentage of absorbance with respect to an untreated control.
In-vitro Transfection
The cells were placed in 24-well plates and incubated with different concentrations of DNA-loaded nanoparticles (100 µl) in 0.5 ml of serum-free medium for 4h at 37°C in a 5% CO 2 atmosphere followed by addition of 0.5 ml of complete fresh medium. After 24h, the cells were washed with PBS and incubated with trypsin/EDTA for 5 min at 37°C. The cells were harvested in 1 ml of complete fresh medium (DMEM for FaDu cells and RPMI 1640 for both MDA-MB 231 and MCF-7) and centrifuged at 1,500 rpm for 10 min to eliminate the trypsin. In a final step, the cells were dispersed in 500 µl of PBS. GFP was excited at 488 nm and its fluorescence signal was detected trough a 510-520 nm band-pass filter. The mean fluorescence intensity of 10,000 individual cells was measured with FACS Calibur flow cytometer and analyzed using Cell Quest ® software program (Becton Dickinson, Le pont-De-Claix, France).
Statistical Analysis
Statistical analysis was performed using a Mann-Whitney test. Data were presented as mean ± SD. p < 0.05 was considered as statistically significant.
Results and Discussion
Characterization of Nanoparticles It is known that particle size significantly affects their cellular uptake and in some cell lines only submicron size particles are efficient (25). Therefore, it was important to determine the size of the Eudragit ® RS and Eudragit ® RL nanoparticles prepared by each method: nanoprecipitation or double emulsion. It has been reported in the literature that nanoprecipitation allowed small nanoparticles (<100 nm) to be obtained (36, 37), whereas double emulsion techniques lead to larger shown), DNA binding was considered as stable during at least 4 hours. In addition, it has to be kept in mind that nanoparticles were prepared extemporaneously: maximum time between nanoparticles preparation and cell transfection studies was 1 hour. As shown in Table I , the zeta potential of the DNA-loaded nanoparticles was affected by the nanoparticles concentration. Overall, the zeta potential of the nanoparticles decreased with the degree of DNA loading. Indeed, for both types of nanoparticles, the zeta potential ranged from high positive values (around + 50 mV) to negative values for the highest DNA loading (-12 mV and -43 mV for Eudragit ® RL nanoparticles obtained by nanoprecipitation and double emulsion at the dose of 500 µg/ml nanoparticles, respectively). Plasmid DNA is a polyanionic molecule which can be loaded on a polycationic surface by ionic interactions. A cationic polymer or a combination of polymers may be used for preparation of cationic particles which, apart from facilitating plasmid loading, also, by virtue of their positive charge, helps in attachment of the particles on cell surface (43). Thus, in the case of Eudragit ® nanoparticles, DNA loading was favored by potential electrostatic binding between the cationic polymer and the negatively charged DNA.
The zeta potential decreased as a function of the quantity of DNA adsorbed onto nanoparticles (Figures 1 and 2A) , which reflects a higher loading for the higher polymer (i.e., nanoparticles) concentration. The observed zeta potentials also depend on the preparation method. Nanoparticles prepared by double emulsion are more negatively charged than nanoparticles prepared by nanoprecipitation. Although a clear explanation has not been found for this observation, it could be due to spatial arrangement of DNA plasmid on the surface. Nevertheless, the zeta potential values reflect the DNA adsorption process for nanoparticles prepared by the same technique. Indeed, there were strong differences in zeta potential values for nanoparticles prepared by double emulsion: so, for double emulsion nanoparticles, zeta potential was a function of DNA adsorption, especially for the highest polymer concentrations. On the other hand, there was no statistical difference in the amount of loaded DNA for nanoparticles prepared by nanoprecipitation (Figure 2A ) and the zeta potential was fairly similar for each polymer concentration.
Quantification of DNA loaded onto Nanoparticles
Determination of DNA loading efficiency
For the nanoparticles prepared by double emulsion, the loading efficiency was determined by UV absorbance. DNA was adsorbed onto the surface of nanoparticles from polymer concentrations as low as 30 µg/ml, and increased with polymer concentration up to 500 µg/ml. The results from the quantitative assay for the loading efficiency of DNA adsorbed onto nanoparticles showed that this depended on the type of polymer used. A higher loading was observed with Eudragit® RL nanoparticles compared with Eudragit® RS nanoparticles. DNA loading efficiency was more than 60% for 250 and 500 µg/ml Eudragit® RL nanoparticles concentration (Figure 1) .
In preliminary trials with the double emulsion technique, we attempted to encapsulate DNA by dissolving it in 1 ml internal aqueous phase. Nanoparticles were easily manufactured but the DNA was totally degraded during the preparation steps, probably because of the high shear energy from sonication during the emulsification process. Therefore, we decided to prepare unloaded nanoparticles and then to allow the DNA to adsorb onto the nanoparticles surface under gentle stirring, thus preserving its integrity. Another advantage of the adsorption technique is that is easily applied to nanoparticles obtained by nanoprecipitation. Therefore, the same adsorption technique was used to bind DNA onto both types of nanoparticles, which was an advantage for comparing transfection as a function of particle size. Adsorption of DNA onto nanoparticles did not significantly change their diameter compared with unloaded particles (Table I) . Although we observed some fluctuations in mean particle size with the amount of adsorbed DNA, there was no definite trend as a function of DNA loading. So it can be concluded that DNA adsorption has no (or limited) effect on particle size for a total of 4 µg added to the system.
Gel electrophoresis
The complexation of DNA with nanoparticles prepared by nanoprecipitation was determined onto an agarose gel since it was not possible to separate these particles from the bulk medium by ultracentrifugation at 42,000 g. An alternative, semi-quantitative, method was chosen. The DNA plasmid was mixed with various amounts of nanoparticles and then subjected to electrophoresis on a 0.8% Tris-borate-EDTA agarose gel ( Figure 2 ). As shown in Figure 2 
Cell Viability
The cytotoxicity of Eudragit ® RS and RL nanoparticles was determined using the MTT assay ( Figure 3 ) in three cell lines over 24h (corresponding to the experimental time used for an invitro transfection). The viability of the three different cell lines was tested in the presence or absence of DNA-nanoparticles at various concentrations of polymer (i.e., nanoparticles) prepared by nanoprecipitation. Cytotoxicity studies and transfection by nanoparticles prepared by nanoprecipitation were carried out nanoparticle concentration for a fixed amount (4 µg) of DNA led to an increase in the amount of DNA bound to nanoparticles. Indeed for the first two lanes of each Eudragit ® (lanes 1, 2 and 6, 7 for Eudragit ® RS and RL, respectively), there were not enough nanoparticles to bind all the nucleic acid and some free DNA was able to migrate into the gel. Despite the higher charge of the Eudragit ® RL nanoparticles, there was no statistical difference from Eudragit ® RS nanoparticles with respect to the amount of DNA bound. The amount of DNA loading is also reflected in the zeta potential results (Figure 2 ).
Concentration of nanoparticles (µg/ml)
Control 30 ▲DNA-RL is statistically different from RL nanoparticle at p < 0.05. ♦DNA-RS is statistically different from RS nanoparticle at p < 0.05. *RL nanoparticle is statistically different from control at p < 0.05. † RS nanoparticle is statistically different from control at p < 0.05. •DNA-nanoparticles "double emulsion" is statistically different from DNA-nanoparticles "nanoprecipitation" at p < 0.05. ╪ RS or RL "double emulsion" nanoparticles is statistically different from RS or RL "nanoprecipitation" at p < 0.05. These results highlight the relationship between size and toxicity, since "large" nanoparticles (range 300-400 nm) were much less toxic than "small" nanoparticles (around 50 nm). This could be attributed to a deleterious action of the polymer after phagocytosis or an effect of many smaller nanoparticles coating the cell surface and preventing exchanges between the nutrient medium and the cells. The comparison also demonstrated that PVA (the surfactant used in the double emulsion technique) did not have any deleterious action on cells despite previous reports (44). Comparison of the effect of unloaded and DNA-loaded nanoparticles showed that there was no significant difference in their impact on cell viability except in the case of FaDu cells in which the DNA-loaded nanoparticles at 125, 250 and 500 µg/ ml were significantly less toxic than unloaded nanoparticles at the same polymer concentration. This was not unexpected since Cherng et al., found that complexes of pDNA with (poly(2dimethylamino)ethyl methacrylate) were less toxic than the cationic polymer alone (45). The mechanism of cytotoxicity caused by polycations is not yet fully understood. Whether their cytotoxic effects are mainly mediated by interactions with cell membranes or by cellular uptake and subsequent activation of intracellular signal transduction pathways, is still being debated in the literature. Furthermore, no investigations have addressed the question of whether this cytotoxicity induced by polycations is apoptotic or necrotic in nature (46).
Transfection efficiency
Transfection was studied in the three cell lines. The transfection efficiency was quantified by a flow cytometry assay. The com-The commercial cationic liposome-based reagent, Lipofectamine 2000 ® (lipofectamine), known to provide high transfection efficiency and a high level of transgene expression in numerous mammalian cell types in vitro (47) was chosen as a positive control.
For nanoparticles prepared by nanoprecipitation, the transfection level was the highest in FaDu cells, whereas MCF-7 cells showed the lowest rate of transfection. In FaDu cells, the rate of transfection of the lipofectamine was between 2and 3 fold higher than the "nanoprecipitation" nanoparticles. These nanoparticles provided a rate of transfection of around 6% for both type of polymer, at all polymer concentrations. At higher concentrations (250 and 500 µg/ml) the rates of transfection decreased slightly. This phenomenon was probably the result of the toxicity observed earlier for this cell line at the highest concentrations.
In MDA-MB 231 cells, the rate of transfection of the lipofectamine was lower (7%) than in FaDu cells (15%). With nanoparticles, the rate of transfection was slightly lower than with lipofectamine. However, it should be noticed that Eudragit ® RL nanoparticles at a concentration of 500 µg/ml showed a transfection rate (7%) that was not not statistically different from that of the lipofectamine control. So, it can in three different cell lines (FaDu, MDA-MB 231 and MCF-7 cells) for three reasons: i) to evaluate the behaviour of different cancer cell lines with the new developed nanoparticles; ii) to determine whether MCF-7 cells, known to be easily transfected, have a different behaviour than other cell lines; iii) to compare the efficacy of transfection with nanoparticles between the invasive (MDA-MB231) and noninvasive (FaDu and MCF-7) cancer cells. Since nanoparticles prepared by the double emulsion technique were more difficult to obtain, they were only evaluated in MCF-7 cells, in comparison with nanoparticles prepared by nanoprecipitation, to investigate any size-related effect in a cell line supposed to offer high transfection rates. Cells incubated in culture medium alone (RPMI or DMEM) were used to obtain values for 100% viability.
Nanoparticles prepared by nanoprecipitation were found to be less toxic towards MDA-MB 231 and MCF-7 cells than towards FaDu cells ( Figure 3A) . DNA-loaded nanoparticles were less cytotoxic than nanoparticles without DNA for polymer concentrations between 125 to 500 µg/ml in FaDu cells, whatever the polymer type. In MDA-MB 231 cells, neither DNA-loaded nanoparticles nor nanoparticles without DNA were toxic, since the viability was maintained at approximately 90% of the control regardless of the polymer type and the concentration of nanoparticles ( Figure 3B) . Lower cytotoxicity was observed in MCF-7 cells with the particles prepared by the double emulsion than with those prepared by the nanoprecipitation technique ( Figure 3D) (Figure 3) .
Of the three cell lines studied with nanoparticles prepared by nanoprecipitation, FaDu cells appeared to be the most sensitive, whereas MDA-MB 231 cells displayed a higher surviving fraction, even for the highest nanoparticle concentration (500 µg/ml) leading to around 90% survival, compared with less than 50% for the FaDu cells. In FaDu cells, DNA adsorption decreased the overall toxicity with statistically significant differences at 250 and 500 µg/ml of Eudragit ® RS nanoparticles. Such an observation could be related to the specific sensitivity of the cell line due to the increased polymer concentration, which was not observed in MDA-MB 231 cells. More neutral or even negative nanoparticles seem also to play a role in the decreased toxicity compared with the high positive values of unloaded nanoparticles. On the other hand, polymer concentration and zeta potential values did not affect viability in MDA-MB 231 cells. The results observed in MCF-7 were intermediate, with more than 50% viability for all conditions tested.
In the MCF-7 cell line, the cytotoxicity of nanoparticles prepared by the double emulsion technique could be compared with that of those prepared by nanoprecipitation. Figure 3D shows that the overall surviving fraction was higher with "double emulsion" nanoparticles than "nanoprecipitation" nanoparticles. For both types of nanoparticles, there were no statistical differences between different concentrations of polymer between 30 and 500 µg/ml. both lipofectamine and nanoparticles and there were no statistical differences between the two polymers and between different concentrations. Surprisingly, the increased toxicity observed at a concentration of 500 µg/ml nanoparticles was not correlated with a lower transfection rate. Despite their low transfection efficiency, MCF-7 cells were selected for testing the "double emulsion" nanoparticles, because the criterion was to have a cell line presenting the same efficiency for the lipofectamine control and the nanoparticles in order to highlight the influence of the particle diameter (Figure 4 ). be deduced that transfection rate is not correlated to cell survival, since nanoparticles have almost no toxic effect on MDA-MB 231 cells. Furthermore, despite a larger number of viable cells, the transfection rate was lower than in FaDu cells, suggesting that transfection efficiency could be directly related to the cell type.
In MCF-7 cells, the rates of transfection of both nanoparticles and lipofectamine were found to be lower than in the other two cell lines. The rate of transfection was similar for figure A, B , C) or by double emulsion ( figure D) , Lipofectamine, and naked DNA. Results are presented as mean values of at least three independent experiments (n=3 ± SD). † DNA-RS is statistically different from lipofectamine at p < 0.05. ♦ DNA-RL RS is statistically different from lipofectamine at p < 0.05. * DNA-RS RS is statistically different from DNA-RL "nanoprecipitation" nanoparticles at p < 0.05. ▲ DNA-RS "double emulsion" nanoparticles is statistically different from DNA-RS "nanoprecipitation" nanoparticles at p < 0.05. • DNA-RL "double emulsion" nanoparticles is statistically different from DNA-RL "nanoprecipitation" nanoparticles at p < 0.05.
The transfection efficiency of nanoparticles prepared by nanoprecipitation was in the range 4 to 7% in both FaDu and MDA-MB 231 cells. Only MCF-7 cells were transfected with nanoparticles prepared by double emulsion ( Figure 4D ) and by nanoprecipitation ( Figure 4C) ; the transfection efficiencies were between 2 and 4%; however, nanoparticles prepared by nanoprecipitation were significantly more efficient than nanoparticles prepared by the double emulsion technique, as shown in Figure 4D . Nevertheless, this is only a trend since there were no statistical differences between 30 to 500 µg/ml of nanoparticles for both types of polymer. Again, the toxicity results with "double emulsion" nanoparticles seem contradictory with the transfection rate, since MCF-7 cells were more sensitive to "nanoprecipitation" than "double emulsion" nanoparticles especially for the highest concentration (500 µg/ ml). The small differences in transfection rate could be due to particle size. Indeed, "smaller" nanoparticles (around 50 nm) would be expected to be more efficient at transfecting than "larger" nanoparticles (range 300-400 nm).
For example, Prahba et al., 2002 , have demonstrated that small PLGA nanoparticles (around 95-130 nm) allowed a better transfection than the same nanoparticles of 300-400 nm on COS-7 and HEK-293 cell lines (28). Overall, Eudragit polycationic nanoparticles did not demonstrate a higher transfection rate than the lipofectamine control. Neither zeta potential nor DNA loading nor even particle size was found to have any dramatic effect on transfection efficiency in any of the 3 cell lines studied.
Conclusion
In this study, we investigated two methods for preparing cationic Eudragit ® RS and RL nanoparticles as non-viral vectors. The double emulsion and nanoprecipitation techniques were used successfully to produce cationic nanoparticles designed to enhance the electrostatic interaction between DNA and the cell membrane. The mean particle size of the nanoparticle was smaller when nanoparticles were made by nanoprecipitation. The cationic Eudragit nanoparticles obtained formed complexes with DNA and could be used for cell transfection. In an in-vitro transfection study using three cell lines, Eudragit nanoparticles complexed with DNA gave GFP expression.
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